Ben Haynor
Stock Analyst at Lake Street
(1.21)
# 3,748
Out of 5,148 analysts
43
Total ratings
38.46%
Success rate
-16.03%
Average return
Main Sectors:
Stocks Rated by Ben Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFLY Butterfly Network | Maintains: Buy | $4 → $5.5 | $3.81 | +44.36% | 2 | Jan 20, 2026 | |
| PIII P3 Health Partners | Maintains: Buy | $20 → $13 | $2.17 | +476.25% | 2 | Nov 17, 2025 | |
| TCMD Tactile Systems Technology | Maintains: Buy | $24 → $32 | $29.33 | +9.10% | 2 | Nov 4, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $37 → $34 | $18.79 | +81.00% | 2 | Oct 10, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $13 → $6 | $4.56 | +31.72% | 5 | Aug 8, 2025 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $15 → $9.5 | $10.13 | -6.22% | 4 | Jul 29, 2025 | |
| ATEC Alphatec Holdings | Assumes: Buy | $18 | $13.40 | +34.33% | 1 | Jun 16, 2025 | |
| LFWD Lifeward | Maintains: Buy | $54 → $48 | $6.83 | +602.78% | 2 | Mar 11, 2025 | |
| TMCI Treace Medical Concepts | Initiates: Buy | $15 | $1.62 | +795.06% | 1 | Dec 31, 2024 | |
| MYO Myomo | Maintains: Buy | $7 → $7.5 | $0.74 | +907.52% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.9 → $2.9 | $0.63 | +358.72% | 3 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $7.39 | +46.14% | 3 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $0.84 | +2,097.67% | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.47 | +487.04% | 1 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.25 → $2.2 | $0.69 | +220.05% | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $82 | $10.99 | +646.13% | 3 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5.55 | $1.54 | +260.39% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.15 → $4.75 | $1.77 | +168.36% | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $0.55 | +4,074.31% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,375 | $2.69 | +51,015.24% | 1 | Jun 26, 2020 |
Butterfly Network
Jan 20, 2026
Maintains: Buy
Price Target: $4 → $5.5
Current: $3.81
Upside: +44.36%
P3 Health Partners
Nov 17, 2025
Maintains: Buy
Price Target: $20 → $13
Current: $2.17
Upside: +476.25%
Tactile Systems Technology
Nov 4, 2025
Maintains: Buy
Price Target: $24 → $32
Current: $29.33
Upside: +9.10%
OrthoPediatrics
Oct 10, 2025
Maintains: Buy
Price Target: $37 → $34
Current: $18.79
Upside: +81.00%
Sensus Healthcare
Aug 8, 2025
Maintains: Buy
Price Target: $13 → $6
Current: $4.56
Upside: +31.72%
Ekso Bionics Holdings
Jul 29, 2025
Maintains: Buy
Price Target: $15 → $9.5
Current: $10.13
Upside: -6.22%
Alphatec Holdings
Jun 16, 2025
Assumes: Buy
Price Target: $18
Current: $13.40
Upside: +34.33%
Lifeward
Mar 11, 2025
Maintains: Buy
Price Target: $54 → $48
Current: $6.83
Upside: +602.78%
Treace Medical Concepts
Dec 31, 2024
Initiates: Buy
Price Target: $15
Current: $1.62
Upside: +795.06%
Myomo
Jul 9, 2024
Maintains: Buy
Price Target: $7 → $7.5
Current: $0.74
Upside: +907.52%
Mar 20, 2024
Maintains: Buy
Price Target: $1.9 → $2.9
Current: $0.63
Upside: +358.72%
Mar 11, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $7.39
Upside: +46.14%
Oct 2, 2023
Initiates: Buy
Price Target: $19
Current: $0.84
Upside: +2,097.67%
Sep 8, 2023
Initiates: Buy
Price Target: $15
Current: $2.47
Upside: +487.04%
Aug 15, 2023
Maintains: Buy
Price Target: $3.25 → $2.2
Current: $0.69
Upside: +220.05%
Aug 11, 2023
Maintains: Buy
Price Target: $109 → $82
Current: $10.99
Upside: +646.13%
May 19, 2023
Maintains: Buy
Price Target: $10 → $5.55
Current: $1.54
Upside: +260.39%
May 17, 2023
Maintains: Buy
Price Target: $5.15 → $4.75
Current: $1.77
Upside: +168.36%
Feb 17, 2023
Initiates: Buy
Price Target: $23
Current: $0.55
Upside: +4,074.31%
Jun 26, 2020
Initiates: Buy
Price Target: $1,375
Current: $2.69
Upside: +51,015.24%